Pulmonary Hypertension with Thalidomide Therapy;Hyperammonemia and Valproate;CNS Toxicity from Improper Use of Cyclopentolate Ophthalmic Drops;Glycemic Control Issues with Gatifloxacin;Infusion Phlebitis with Cyclosporine;Acute Hypersensitivity Reaction to HIV Fusion Inhibitor;Imatinib-Induced Hepatotoxicity
Restricted accessResearch articleFirst published online February, 2005
Pulmonary Hypertension with Thalidomide Therapy;Hyperammonemia and Valproate;CNS Toxicity from Improper Use of Cyclopentolate Ophthalmic Drops;Glycemic Control Issues with Gatifloxacin;Infusion Phlebitis with Cyclosporine;Acute Hypersensitivity Reaction to HIV Fusion Inhibitor;Imatinib-Induced Hepatotoxicity
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
Get full access to this article
View all access options for this article.
References
1.
YounisT.H.Reversible pulmonary hypertension and thalidomide therapy for multiple myeloma.Br J Haematol.2003; 121(1): 191–192.
2.
ShusterJ.ISMP adverse drug reactions: hyperammonemia with valproic acid.Hosp Pharm.2004; 39(11): 1025–1026.
3.
KhovidhunkitW., SunthornyothinS.Hypoglycemia, hyperglycemia, and gatifloxacin.Ann Int Med.2004; 141(12): 969.
4.
HappeM.R., MulhallB.P., MaydonovitchC.L.Gatifloxacin-induced hyperglycemia.Ann Int Med.2004; 141(12): 968–969.
5.
ShusterJ.ISMP adverse drug reactions: two problems with fluoroquinolones.Hosp Pharm.2002; 37(11): 1145–1146.
6.
RottenbergY., FridlenderZ.G.Recurrent infusion phlebitis induced by cyclosporine.Ann Pharmacother.2004; 38(12): 2071–2073.
7.
BeilkeM.A.Acute hypersensitivity reaction to enfuvurtide upon re-challenge.Scand J Infect Dis.2004; 36(10): 778.
